PharmaTalkRadio

PharmaTalkRadio

Download on the App Store

All PharmaTalkRadio episodes

  • How to Embed Clinical Research in Rural and Frontier Health Systems
    About this podcast:
    This session was recorded at the September 2025 CRAACO: Clinical Research as a Care Option conference.

    Rural sites represent untapped potential for reaching a broader array of patients and providing them access to life-changing clinical trials, but existing clinical trial infrastructure does not set rural sites up for success. 

    Funded through the Genentech Innovation Fund, Montana State University and Billings Clinic created a rural clinical research readiness toolkit for unaffiliated rural and frontier healthcare systems to empower them to meet clinical research demands without compromising local care delivery.

    More specifically, this presentation covers the tools created to toolkit empowers sites to do clinical research, including:
    • Interpretable workflow templates
    • A workload calculator for staff capacity planning
    • Patient safety indicators to support enrollment and retention
    • EHR-based visualization methods to assist clinical decision-making when trial participants are also patients
    • And more
    For more information, go to theconferenceforum.org.
    20 min
  • Optimizing the Value Proposition in Small Companies with Limited Budgets
    This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how CMOs can support value creation in biotechs and how that is influenced buy the current biotech financial climate. Specifically:
    • The importance of storytelling and leading thoughtfully
    • Effective prioritization and execution towards the company narrative
    • Balancing the team to be lean while avoiding the potential pitfalls of running lean
    • Balancing the data collected to be interesting to investigators and important for the program to proceed
    • Clinical data generation is better than preclinical dreams
    • Strategically choosing a first indication and building sufficient scientific bridging to support subsequent indications
    To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
    31 min
  • From the DPHARM 2024 Archives: Biogen Pilot on Using Vocal Biomarkers to Identify Potential Participants for Clinical Trials
    In this podcast from the DPHARM 2024 archives, Biogen discussed how they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to provide access to patients  with a clinically validated cognitive assessment who might not otherwise have the foundation to start a conversation with their physician about their cognition. 

    For more information, go to DPHARMconference.com
    22 min
  • Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement
    At the March 2025 Patients as Partners conference, Merck presents how they advancing patient and community engagement through targeted initiatives designed to improve trial participation, relevance, and long-term impact. Key topics include:
    • Identifying and addressing patient and community needs
    • Strategies for earning trust and fostering sustained engagement
    • Key collaborations and partnerships driving meaningful change
    • Approaches to developing patient-centered endpoints and outcomes
    • Methods for effectively communicating and disseminating trial results
    For more information, go to PatientsAsPartnersConference.com
    19 min
  • Ensuring Continuity in Patient Insights to Strengthen Medicine Development
    Summary: 

    This session was recorded at the March 2025 Patients as Partners conference. In this session, Pfizer addressed how they were working to ensure continuity in the patient insights they were collecting, throughout the product life cycle. This included: 
    • Approaches for aligning internal processes to facilitate the seamless flow of patient insights from early-phase to late-phase teams
    • Suggested tools, including an AI Insights tool designed to centralize and leverage previous patient feedback, supporting a more integrated approach to patient engagement
    • Strategies to build on existing insights, enhance collaboration across teams, and drive more effective patient-centered outcomes in R&D processes
    For more information, go to PatientsAsPartnersConference.com.





    19 min
  • Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach
    Summary: 

    From the DPHARM Archives, this podcast was recorded at the September 2024 DPHARM conference. In this podcast, BMS present how they specifically targeted the challenge of recruiting patients for clinical trials, aiming to make the process faster and easier. By bringing trials directly to patients, their ultimate objective was to significantly expedite patient enrollment. In this case example, they brought the audience through their new product model approach, for the organization's overarching goal of reducing the drug timeline from discovery to launch by three years.
    17 min
  • Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy
    About this podcast:
    Recorded at the 2025 Immuno-Oncology 360º Summit, Stanford University's Dr Crystal Mackall shares work from her lab developing GD2-targeting CAR T cell therapy for the treatment of deadly pediatric brain tumor, as well as broader lessons on the evolution of cell therapy, and her forward-looking perspective on shaping the next generation of cancer treatments.

    For more information, go to IO360summit.com. 
    29 min
  • De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing
    Summary:
    Rescuing a clinical trial and choosing to switch vendor's mid-trial are some of the most expensive decisions biotech CMOs can make. These rescues require a significant amount of time, money and energy and may not even address the root issue behind a trial's poor performance. In this podcast, Raul Lima, SVP, Strategic Clinical Operations, inSeption Group, discusses a scaffolding approach that prioritizes areas that require immediate support without sacrificing the entirety of the trial. Specifically:
    • How biotechs can better identify root causes of issues and correct them
    • Mistakes CMOs make when implementing rescues
    • When and how a scaffolding approach can be more resource, time and financially efficient
    For more information about inSeption Group, visit inSeptionGroup.com. 

    For more information about the annual Chief Medical Officer Summit 360° and its affiliated editorials, podcasts and webcasts, please visit CMO360.org.
    29 min
  • Balancing Between Concentration and Volume when Developing Patient-Centric Biologics
    Summary:
    When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning and coordinating the formulation and device activities. In this podcast, Pharma and Drug Delivery executives from Nanoform, Pfizer, GSK, Takeda and Kymanox discuss how they facilitate partnerships between drug product development, device engineering and clinical study teams to determine how to balance concentration and volume and develop optimal devices for delivery and commercialization. Specifically:
    • Impact on increasing concentration of drugs on deliverability
    • Technical feasibility of manufacturing larger volume devices
    • Patient tolerability and human factors that impact patient adherence
    This panel discussion was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.
    29 min